Published in Ir Med J on February 04, 1997
Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group. CMAJ (1999) 7.05
Interventions used in disease management programmes for patients with chronic illness-which ones work? Meta-analysis of published reports. BMJ (2002) 6.98
Written action plans for asthma: an evidence-based review of the key components. Thorax (2004) 3.62
Objectives, methods and content of patient education programmes for adults with asthma: systematic review of studies published between 1979 and 1998. Thorax (1999) 1.73
Effectiveness and success factors of educational inhaler technique interventions in asthma & COPD patients: a systematic review. NPJ Prim Care Respir Med (2017) 0.75
The human VASA gene is specifically expressed in the germ cell lineage. Proc Natl Acad Sci U S A (2000) 2.56
Tranexamic acid and rectal bleeding. Lancet (1991) 1.97
Predictive value of clinical features for the obstructive sleep apnoea syndrome. Eur Respir J (1996) 1.91
Effect of supplemental nocturnal oxygen on gas exchange in patients with severe obstructive lung disease. N Engl J Med (1984) 1.88
Pathophysiology of obstructive sleep apnoea. Eur Respir J (1995) 1.85
Cardiovascular risk factors in patients with obstructive sleep apnoea syndrome. Eur Respir J (2000) 1.80
Reversible hypercapnia in chronic obstructive pulmonary disease: a distinct pattern of respiratory failure with a favorable prognosis. Am J Med (1997) 1.76
Hypoxaemia during chest physiotherapy in patients with cystic fibrosis. Ir J Med Sci (1986) 1.74
Management of obstructive sleep apnea in Europe. Sleep Med (2010) 1.56
Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome? Thorax (2009) 1.45
Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation. Eur Respir J (2009) 1.43
Use of self-collected vaginal specimens for detection of Chlamydia trachomatis infection. Obstet Gynecol (1998) 1.38
Cardiac rhythm disturbances in the obstructive sleep apnea syndrome: effects of nasal continuous positive airway pressure therapy. Chest (2000) 1.35
Obstructive apneas during sleep in patients with seasonal allergic rhinitis. Am Rev Respir Dis (1982) 1.18
Rapid changes in plasma potassium during a game of squash. Clin Sci (Lond) (1988) 1.18
Public health and medicolegal implications of sleep apnoea. Eur Respir J (2002) 1.14
Is sleep apnoea more common in North America? Lancet (1982) 1.14
Role of respiratory sleep disorders in the pathogenesis of nocturnal angina and arrhythmias. Postgrad Med J (1994) 1.11
Inspiratory flow limitation during sleep in pre-eclampsia: comparison with normal pregnant and nonpregnant women. Eur Respir J (2001) 1.10
Two outbreaks of Legionnaires' disease in Bolton Health District. Epidemiol Infect (1990) 1.05
Bed partners' assessment of nasal continuous positive airway pressure therapy in obstructive sleep apnea. Chest (1997) 1.01
Effects of positive airway pressure on upper airway dilator muscle activity and ventilatory timing. J Appl Physiol (1985) (1996) 1.00
Ongoing outbreak of Shigella flexneri serotype 3a in men who have sex with men in England and Wales, data from 2009-2011. Euro Surveill (2012) 1.00
Acute stridor due to an upper tracheal membrane following endotracheal intubation. Eur Respir J (1999) 1.00
The nose and OSA: variable nasal obstruction may be more important in pathophysiology than fixed obstruction. Eur Respir J (2008) 0.99
Hypovitaminosis D and response to supplementation in older patients with cystic fibrosis. Q J Med (1985) 0.99
Nocturnal deaths among patients with chronic bronchitis and emphysema. Br Med J (Clin Res Ed) (1984) 0.99
Investigation of an outbreak of cryptosporidiosis associated with treated surface water finds limits to the value of case control studies. Commun Dis Public Health (1998) 0.99
Subjective efficacy of nasal CPAP therapy in obstructive sleep apnoea syndrome: a prospective controlled study. Eur Respir J (1999) 0.98
Reflex respiratory response to changes in upper airway pressure in the anaesthetized rat. J Physiol (2001) 0.97
Obstructive sleep apnea following topical oropharyngeal anesthesia in loud snorers. Am Rev Respir Dis (1991) 0.97
Controlled oxygen therapy and carbon dioxide retention during exacerbations of chronic obstructive pulmonary disease. Lancet (2001) 0.97
Theophylline improves gas exchange during rest, exercise, and sleep in severe chronic obstructive pulmonary disease. Am Rev Respir Dis (1993) 0.96
Haemodynamic effects of nasal continuous positive airway pressure in severe congestive heart failure. Eur Respir J (1995) 0.94
Intranasal corticosteroid therapy for obstructive sleep apnoea in patients with co-existing rhinitis. Thorax (2004) 0.93
Insulin and multiplication stimulating activity (an insulin-like growth factor) stimulate islet (beta-cell replication in neonatal rat pancreatic monolayer cultures. Diabetes (1982) 0.92
Adipose tissue in obesity and obstructive sleep apnoea. Eur Respir J (2011) 0.91
Ventilation and gas exchange during sleep in patients with interstitial lung disease. Thorax (1986) 0.91
Theophylline in obstructive sleep apnea. A double-blind evaluation. Chest (1992) 0.90
Comparison of three auto-adjusting positive pressure devices in patients with sleep apnoea. Eur Respir J (2006) 0.89
Microphthalmia transcription factor: not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma. Am J Dermatopathol (2001) 0.88
Beneficial effect of oxygen in primary alveolar hypoventilation with central sleep apnea. Am Rev Respir Dis (1982) 0.88
Clear cell sarcoma shows immunoreactivity for microphthalmia transcription factor: further evidence for melanocytic differentiation. Mod Pathol (2001) 0.87
Ventilation and gas exchange during sleep and exercise in severe COPD. Chest (1996) 0.85
Comparison of a limited computerized diagnostic system (ResCare Autoset) with polysomnography in the diagnosis of obstructive sleep apnoea syndrome. Eur Respir J (1996) 0.85
Abnormal respiratory pattern generation during sleep in patients with autonomic dysfunction. Am Rev Respir Dis (1983) 0.85
Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome? Postgrad Med J (2009) 0.85
Honeycomb cysts in idiopathic pulmonary haemosiderosis: high-resolution CT appearances in two adults. Br J Radiol (2008) 0.84
Compliance at night with low flow oxygen therapy: a comparison of nasal cannulae and Venturi face masks. Thorax (1995) 0.84
Comparison of oxygen desaturation during sleep and exercise in patients with cystic fibrosis. Chest (1991) 0.84
Diagnostic criteria for the sleep apnoea syndrome: time for consensus. Eur Respir J (1996) 0.84
Upper airway obstruction during sleep in normal subjects after selective topical oropharyngeal anesthesia. Am Rev Respir Dis (1987) 0.83
Clinical and physiologic heterogeneity of the central sleep apnea syndrome. Am Rev Respir Dis (1986) 0.82
Sarcoidosis presenting as upper extremity venous thrombosis. Thorax (2003) 0.82
A role for endogneous prostaglandins in the short-circuit current responses to osmolal changes in isolated frog skin. J Physiol (1977) 0.82
Late-onset central hypoventilation syndrome: a family genetic study. Eur Respir J (2007) 0.82
Efficacy of nasal continuous positive airway pressure therapy in chronic heart failure: importance of underlying cardiac rhythm. Thorax (1998) 0.82
Growth hormone stimulates islet B-cell replication in neonatal rat pancreatic monolayer cultures. Diabetes (1983) 0.81
Portable monitoring in sleep apnoea: the way forward? Eur Respir J (2011) 0.81
Sleep-related breathing disorders: definitions and measurements. Eur Respir J (2000) 0.81
Treatment of Robin sequence with nasal CPAP. J Laryngol Otol (1995) 0.80
Latitudinal variation in the prevalence of multiple sclerosis in Ireland, an effect of genetic diversity. J Neurol Neurosurg Psychiatry (2004) 0.80
Impaired detection of added inspiratory resistance in patients with obstructive sleep apnea. Am Rev Respir Dis (1984) 0.80
Popliteal cyst rupture and the pseudothrombophlebitis syndrome. Ann Emerg Med (1987) 0.80
Towards automated sleep state estimation using a Holter-oximeter. Conf Proc IEEE Eng Med Biol Soc (2007) 0.80
Reversible hypercapnia in acute exacerbations of chronic obstructive pulmonary disease (COPD). Eur Respir J (1993) 0.80
Topical oropharyngeal anesthesia in patients with obstructive sleep apnea. Am J Respir Crit Care Med (1995) 0.79
Upper lobe bronchiectasis in the yellow nail syndrome: report of a case. Ir J Med Sci (1984) 0.79
Compliance with nasal CPAP therapy for obstructive sleep apnoea: how much is enough? Eur Respir J (1997) 0.79
A national outbreak of verotoxin-producing Escherichia coli O157 associated with consumption of lemon-and-coriander chicken wraps from a supermarket chain. Epidemiol Infect (2009) 0.78
Paradoxical vocal cord motion causing stridor after thyroidectomy. Thorax (2000) 0.78
Comparison of nebulized and sprayed topical anaesthesia for fibreoptic bronchoscopy. Eur Respir J (1992) 0.78
A foodborne outbreak of Salmonella Bareilly in the United Kingdom, 2010. Euro Surveill (2010) 0.78
Clinical prediction of the sleep apnea syndrome. Sleep Med Rev (1997) 0.77
Adrenaline causes potassium influx in skeletal muscle and potassium efflux in cardiac muscle in rats: the role of Na/K ATPase. Life Sci (1987) 0.77
Resolution of obstructive sleep apnoea with growth in the Robin sequence. Eur Respir J (1998) 0.77
The asthma specialist and patient education. Prof Nurse (1995) 0.77
Oxygen desaturation during sleep and exercise in patients with severe chronic obstructive pulmonary disease. Respir Med (1995) 0.76
Acute respiratory failure in pregnancy due to staphylococcal pneumonia. Ir Med J (1983) 0.76
Promoting sexual health. BMJ (1992) 0.75
An unusual cause of orthopnoea. Postgrad Med J (1996) 0.75
Control of communicable disease. Compulsory removal powers inappropriate. BMJ (1993) 0.75
Postmortem changes in blood amitriptyline concentration. Am J Forensic Med Pathol (1994) 0.75
Nifedipine for hiccups. J Pain Symptom Manage (1997) 0.75
Malignant chondroid syringoma presenting as multiple pulmonary nodules. Thorax (1997) 0.75
Arousal in the sleep apnoea syndrome: a mixed blessing? Eur Respir J (1998) 0.75
Effect of obesity in patients with coronary artery disease. Lancet (2006) 0.75
Health professionals' attitudes to MMR vaccine. Format of "green book" should be changed. BMJ (2001) 0.75
Continuous non-invasive monitoring of evolving acute severe asthma during sleep. Thorax (1994) 0.75
Postgraduate research training. Palliat Med (1996) 0.75
Survey of raw egg use by home caterers. Commun Dis Public Health (2000) 0.75
Sleep apnoea and driving risk. European Respiratory Society Task Force on "Public Health and Medicolegal Implications of Sleep Apnoea". Eur Respir J (1999) 0.75
Unsuspected self-poisoning with flecainide and alcohol. J Forensic Sci (1995) 0.75
5HT3 receptor antagonists and pruritus due to cholestasis. Palliat Med (1996) 0.75
Modelling to assist in wastewater collection system odour and corrosion potential evaluations. Water Sci Technol (2004) 0.75
An outbreak of measles in Trafford. Commun Dis Rep CDR Rev (1994) 0.75
Outcome of an exercise to notify patients treated by an obstetrician/gynaecologist infected with HIV-1. Commun Dis Rep CDR Rev (1994) 0.75
Sleepiness, sleep apnoea and driving risk. Ir Med J (2001) 0.75
Sleep apnoea in the British Isles. Lancet (1986) 0.75